We use cookies to make sure our website better meets your expectations.
You can adjust your web browser's settings to stop accepting cookies. For further information, read our cookie policy.
SEARCH
IN Warsaw
Exchange Rates
Warsaw Stock Exchange - Indices
Special guest
You have to be logged in to use the ReadSpeaker utility and listen to a text. It's free-of-charge. Just log in to the site or register if you are not registered user yet.
NewDiabetes Drug Within Reach
May 31, 2012   
Article's tools:
Print

Type-2 diabetes, also called non-insulin-dependent diabetes, is a serious public health problem in the modern world. Today 180 million people suffer from the condition, including about 2 million Poles; the number of those affected grows by about 11 percent each year. The World Health Organization predicts that over 350 million people will have the condition by 2030. Each year almost 4 million people die from complications of type-2 diabetes.

The main cause of type-2 diabetes is the body not producing enough insulin or the body cells not responding properly to insulin. In those affected, the hormone is released into the blood improperly or in insufficient amounts. With time, the patient may also develop insulin resistance and loss of function of pancreatic secretion cells. Glucose levels in the body become elevated, leading to damage of many different organs, mainly the eyes, heart, brain and kidneys, in addition to increased susceptibility to other diseases.

Experts say that the incidence of diabetes rises with increasing prosperity and wealth in societies.

Developing an effective and safe drug is important not just for the good of patients but also due to the huge social costs caused by diabetes, so pharmaceutical laboratories across the world are working to develop such drugs.

Adamed has been working on the new diabetes drug in partnership with researchers from institutions such as the University of Warsaw, the Jagiellonian University in Cracow, and the Medical University of Gdańsk.

The scientists say the new drug will work in a different way to insulin, which is mainly used to treat type-1 diabetes, which involves a shortage of insulin and elevated glucose levels
Latest articles in The Polish Science Voice
Latest news in The Polish Science Voice
Mercure - The 6 Friends Theory - Casting call
© The Warsaw Voice 2010-2018
E-mail Marketing Powered by SARE